Results 231 to 240 of about 92,443 (271)
Summary Developing new therapeutic regimens for relapsed/refractory (R/R) B non‐Hodgkin lymphoma (NHL) patients remains a significant unmet clinical need. Our objective was to evaluate atezolizumab (ATE), obinutuzumab (OBI) and venetoclax (VEN) combination in patients with R/R NHL who had received at least one prior anti‐CD20‐containing ...
Charles Herbaux+21 more
wiley +1 more source
Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen+3 more
wiley +1 more source
In Vivo Reprogramming Highlights Epigenetic Regulation That Shapes Cancer Hallmarks
In this review, the authors first introduce genetic aberrations that cause cancer development. Then, they illustrate the impact of epigenetic abnormalities in cancer, especially with reference to studies that use in vivo reprogramming technologies. Finally, the authors discuss the importance of histological evaluations of tumor tissue to understand non‐
Yosuke Yamada+2 more
wiley +1 more source
ABSTRACT Introduction The aim was to analyse mortality and estimate the life expectancy among people hospitalised for alcohol use disorders (AUD) compared with the general Czech population aged ≥20 years. A temporal perspective on excess mortality was used, covering three recent calendar periods before and during the pandemic.
Ladislav Kážmér+2 more
wiley +1 more source
Objectives This study aimed to investigate the diagnostic performance and safety of endoscopic ultrasound‐guided tissue acquisition (EUS‐TA) for perivascular soft‐tissue cuffing (PSTC). Methods This single‐center, retrospective study evaluated patients in whom EUS‐TA was performed for PSTC in pancreatic or bile duct cancer lesions between October 2017 ...
Kosuke Maehara+15 more
wiley +1 more source
Endoscopic intraductal radiofrequency ablation (ID‐RFA) can curatively treat residual intraductal lesions after endoscopic papillectomy. This study aimed to verify the tissue invasiveness of ID‐RFA using a novel RF generator and to explore its appropriate settings in an animal experiment, followed by a small clinical study.
Kenjiro Yamamoto+12 more
wiley +1 more source
Endoscopic management of primary sclerosing cholangitis
Primary sclerosing cholangitis (PSC) is a progressive autoimmune hepatobiliary disease characterized by fibrotic strictures in the bile ducts, leading to chronic cholestasis and cirrhosis. Magnetic resonance cholangiopancreatography (MRCP) is a noninvasive method for evaluating the condition of the bile ducts, and has high sensitivity and specificity ...
Suguru Mizuno+8 more
wiley +1 more source
Endoscopic diagnosis of immunoglobulin G4‐related sclerosing cholangitis
Immunoglobulin G4 (IgG4)‐related sclerosing cholangitis (IgG4‐SC) is a distinct form of sclerosing cholangitis frequently associated with autoimmune pancreatitis and is recognized as a biliary manifestation of IgG4‐related disease. Endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasonography (EUS) are key diagnostic modalities ...
Itaru Naitoh+2 more
wiley +1 more source
Abstract Glycaemic therapy in type 1 diabetes (T1D) is focused on insulin, with the majority of studies investigating different insulin preparations, delivery devices and dosing accuracy methods. While insulin deficiency is the key mechanism for hyperglycaemia in T1D, individuals with this condition can also develop insulin resistance (IR), making ...
Ahmad M. Rajab+2 more
wiley +1 more source
Abstract Aims To investigate the associations of intra‐pancreatic fat deposition (IPFD) with very‐low‐density lipoprotein (VLDL), intermediate‐density lipoprotein (IDL) and lipoprotein lipase. Materials and methods A total of 174 participants underwent magnetic resonance imaging on a 3.0 Tesla scanner for the quantification of IPFD.
Yutong Liu+5 more
wiley +1 more source